Love Your Heart

November 15, 2022

Mavacamten: A Game Changer for Patients with HCM

Hypertrophic cardiomyopathy (HCM) causes thickening of the heart muscle, left ventricular stiffness, mitral valve changes and cellular changes. For many years, management of this condition was surgery or alcohol ablation. Mavacamten is the first FDA approved drug to help treat patients with HCM. Drs. Steven Nissen and Milind Desai talk about this novel treatment option and the benefits of being treated by a specialized center.

November 7, 2022

The Importance of Screening and Monitoring with Aortic Disease

The aorta (the main artery that carries blood away from your heart) can become damaged and weak, causing it to become wider (aneurysm) or torn (dissection). Dr. Frank Caputo discusses, along with Drs. Eric Roselli and Milind Desai, the importance of screening not just for you, but your family too.

November 2, 2022

Good Today, Bad Tomorrow. How to Know What Foods Are Healthy

Changing the way you eat can be challenging not only because it is a lifestyle change, but the recommendations are always changing too. Julia Zumpano, a registered dietitian in the Department of Preventive Cardiology, explains how to find reliable information and find a solution that is right for you.

October 25, 2022

Congenital Heart Disease and the Pulmonic Valve

Congenital heart disease and pulmonic valve disease require a coordinated team approach that includes an initial evaluation, explanation of therapeutic options, innovative transcatheter and surgical therapies and consultative follow-up. Dr. Joanna Ghobrial discusses diagnosis and management for patients with a leaky or tight pulmonic valve.